BioMark Diagnostics Inc. (BUX) — research page
CA · ca-cm-kg/CSE/BUX · as of 2026-11-06
Identity and listing
BioMark Diagnostics Inc. is listed on the CSE under ticker BUX. Its LEI is 529900UHZ378KKXOLY69; its ISIN is not on the record. Security type is Corporate, sector Life Sciences, jurisdiction British Columbia (CA-BC). Segment is not on the record. Listing status is listed, not halted.
| field | value | source · read date |
|---|---|---|
| name | BioMark Diagnostics Inc. | source · 2026-11-06 |
| exchange | CSE | source · 2026-11-06 |
| ticker | BUX | source · 2026-11-06 |
| ISIN | not on the record | |
| LEI | 529900UHZ378KKXOLY69 | source · 2026-11-06 |
| security type | Corporate | source · 2026-11-06 |
| segment | not on the record | |
| sector | Life Sciences | source · 2026-11-06 |
| jurisdiction | British Columbia (CA-BC) | source · 2026-11-06 |
| status | listed, not halted | source · 2026-11-08 |
The disclosure read
The record holds 8 filings in the twelve months to 2026-11-06, on 7 filing days, all of them newswire releases. The median gap between filing days is 45.0 days. The latest filing is dated 2026-09-21, 46 days before the record date. The CSE median gap is 19.5 days across 724 issuers, and the Life Sciences median gap is 17.5 days across 200 issuers. The CSE median latency is 17.0 days and the Life Sciences median latency is 14 days; the issuer's median filings are 6.0 on the CSE and 7.0 in Life Sciences.
| filings | median gap between filing days | days from latest filing to as-of | |
|---|---|---|---|
| this issuer | 8 | 45 | 46 |
| exchange median: CSE (724 issuers) | 6 | 19.5 | 17 |
| sector median: Life Sciences (200 issuers) | 7 | 17.5 | 14 |
| date | type | category | filing |
|---|---|---|---|
| 2026-09-21 | newswire_release | BioMark Announces Participation in upcoming MSACL 2026 and BIOHorizon 2026 Life Sciences Conferences | |
| 2026-09-21 | newswire_release | BioMark Announces Participation in upcoming MSACL 2026 and BIOHorizon 2026 Life Sciences Conferences | |
| 2026-07-31 | newswire_release | BioMark Diagnostics Endorses Global Call for Equitable Access to Early Screening on 2026 World Lung Cancer Day | |
| 2026-06-23 | newswire_release | BioMark Diagnostics Secures Landmark Canadian and European Patent Allowances for Early-Stage Lung Cancer Blood Test | |
| 2026-04-14 | newswire_release | BioMark Diagnostics to Present Liquid Biopsy Platform at the ... |
window 2025-11-06 to 2026-11-06 · the node's disclosure lines, as get_filings serves them
Auditor
The auditor of record is MNP LLP; its location is not on the record. The record holds no auditor changes.
Events and halts
The record holds no listing, delisting, name change, domicile change or segment move events. The halt flag is listed, not halted.
Orderability
For paragraph (o) of the definition the signal is ACM-200 and the outcome is determinable. For paragraph (q) of the definition the signal is ACM-200 and the outcome is determinable. The rule version is acm-68000/ca/kyp-know-your-product-ni-31-103/r1, chapter as of 2026-11-04.
| client category | outcome |
|---|---|
| Paragraph (o) of the definition | ACM-200 |
| Paragraph (q) of the definition | ACM-200 |
rule acm-68000/ca/kyp-know-your-product-ni-31-103/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability
Coverage
The research-house coverage field has not been read.
Open research
The openly published research field has not been read.
Licensed
Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.
| licensor | entitlement | title | date | source |
|---|---|---|---|---|
| none loaded |
As-of depth
The market's vintage is not sealed. The issuer has no sealed years on the record. The live record began 2026-09-10. The store holds sealed years 2021 through 2026 for this issuer but they are not served as of a date; the as-of door answers not_sealed.
Sources
7 source pages are named on this page; every value above carries its own source page and read date in the numbers.
- 10.1
- https://thecse.com/api/webapi/listed-companies/ (identity.exchange)
- 10.2
- https://api.gleif.org/api/v1/lei-records/529900UHZ378KKXOLY69 (identity.jurisdiction)
- 10.3
- https://mcp.ca-cm-kg.ai/events/CSE/BUX (the disclosure lines)
- 10.4
- https://iiroc.mediaroom.com/index.php?s=2429&l=100 (the halt flag)
- 10.5
- https://thecse.com/listings/biomark-diagnostics-inc/ (the auditor)
- 10.6
- https://mcp.ca-cm-kg.ai/book/aio.json (the orderability chapter)
- 10.7
- https://mcp.ca-cm-kg.ai/record/CSE/BUX (the record)
Read it by agent
The same page, signed and receipted: get_research at https://mcp.getresearch.ai/mcp with {"ticker":"BUX","exchange":"CSE"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:51be6e1ba7be561d.